Department of Neurology, Washington University in St. Louis, MO, USA.
Department of Neurology, Washington University in St. Louis, MO, USA.
Biomed J. 2022 Feb;45(1):27-37. doi: 10.1016/j.bj.2021.08.010. Epub 2021 Sep 2.
Drug-resistant epilepsy, characterized by ongoing seizures despite appropriate trials of anti-seizure medications, affects approximately one-third of people with epilepsy. Brain stimulation has recently become available as an alternative treatment option to reduce symptomatic seizures in short and long-term follow-up studies. Several questions remain on how to optimally develop patient-specific treatments and manage therapy over the long term. This review aims to discuss the clinical use and mechanisms of action of Responsive Neural Stimulation and Deep Brain Stimulation in the treatment of epilepsy and highlight recent advances that may both improve outcomes and present new challenges. Finally, a rational approach to device selection is presented based on current mechanistic understanding, clinical evidence, and device features.
耐药性癫痫,其特征是尽管进行了适当的抗癫痫药物试验,但仍持续发作,影响约三分之一的癫痫患者。在短期和长期随访研究中,脑刺激最近已成为一种替代治疗选择,可减少症状性癫痫发作。关于如何优化制定针对患者的治疗方法以及长期管理治疗,仍存在一些问题。本综述旨在讨论反应性神经刺激和深部脑刺激在癫痫治疗中的临床应用和作用机制,并强调可能改善治疗效果并带来新挑战的最新进展。最后,根据目前的机制理解、临床证据和设备特点,提出了一种合理的设备选择方法。